LTC LCS Heart Failure Update
The 4 pillars of heart failure management improve morbidity and mortality outcomes for the right patients. Do you know your HFpEF from your HFrEF or HFmrEF? In September 2025 NICE significantly changed the guidance of how we should be managing heart failure. Drugs we never previously used for heart failure with preserved ejection fraction are now recommended and the use of sacubitril- valsartan and the place of A2RBs has changed.
Join us for a webinar with Dr Chris Primus, Heart Failure Lead Consultant at UCLH and Chair of the North London Cardiac Conditions Operational Delivery Network to cover
When to suspect heart failure and when to refer
What to do whilst awaiting secondary care input
New Guideline on management of different types of heart failure
How and when to uptitrate drugs and what support is available across NCL
For any queries, please contact: